Stent-related cardiac events beyond three years after implantation of the sirolimus-eluting stent (from the EVASTENT patients)

American Journal of Cardiology

Volumn 108, Issue 10, 2011, Pages 1401-1407

  Barone Rochette, Gilles ^a   Foote, Alison ^a   Motreff, Pascal ^b   Vanzetto, Gerald ^a   Quesada, Jean Louis ^a   Danchin, Nicolas ^c   MacHecourt, Jacques ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; INSULIN; RAPAMYCIN;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVASCULARIZATION; STENT THROMBOSIS;

COHORT STUDIES; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PLATELET AGGREGATION INHIBITORS; REGISTRIES; SIROLIMUS; TICLOPIDINE;

EID: 80255140412     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.07.004     Document Type: Article

References (27)

1. E. Camenzind, P.G. Steg, and W. Wijns Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern Circulation 115 2007 1440 1455 (Pubitemid 46648381)
2. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1028
3. C. Spaulding, J. Daemen, E. Boersma, D.E. Cutlip, and P.W. Serruys A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 989 997 (Pubitemid 46376799)
4. G.W. Stone, J.W. Moses, S.G. Ellis, J. Schofer, K.D. Dawkins, M.C. Morice, A. Colombo, E. Schampaert, E. Grube, A.J. Kirtane, D.E. Cutlip, M. Fahy, S.J. Pocock, R. Mehran, and M.B. Leon Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008 (Pubitemid 46376800)
5. A. Kastrati, J. Mehilli, J. Pache, C. Kaiser, M. Valgimigli, H. Kelbaek, M. Menichelli, M. Sabaté, M.J. Suttorp, D. Baumgart, M. Seyfarth, M.E. Pfisterer, and A. Schömig Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039 (Pubitemid 46376803)
6. S.K. James, U. Stenestrand, J. Lindbck, J. Carlsson, F. Scherstén, T. Nilsson, L. Wallentin, B. Lagerqvist SCAAR Study Group Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden N Engl J Med 360 2009 1933 1945
7. J. Daemen, P. Wenaweser, K. Tsuchida, L. Abrecht, S. Vaina, C. Morger, N. Kukreja, P. Jni, G. Sianos, G. Hellige, R.T. van Domburg, O.M. Hess, E. Boersma, B. Meier, S. Windecker, and P.W. Serruys Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678 (Pubitemid 46281313)
8. J. Machecourt, N. Danchin, J.M. Lablanche, J.M. Fauvel, J.L. Bonnet, S. Marliere, A. Foote, J.L. Quesada, H. Eltchaninoff, G. Vanzetto EVASTENT Investigators Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry J Am Coll Cardiol 50 2007 501 508 (Pubitemid 47126769)
9. K.J. Rothman Modern Epidemiology 1986 Little, Brown Boston/Toronto 155 175
10. P. Wenaweser, J. Daemen, M. Zwahlen, R. van Domburg, P. Jni, S. Vaina, G. Hellige, K. Tsuchida, C. Morger, E. Boersma, N. Kukreja, B. Meier, P.W. Serruys, and S. Windecker Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice 4-Year results from a large 2-institutional cohort study J Am Coll Cardiol 52 2008 1134 1140
11. A. Caixeta, M.B. Leon, A.J. Lansky, E. Nikolsky, J. Aoki, J.W. Moses, J. Schofer, M.C. Morice, E. Schampaert, A.J. Kirtane, J.J. Popma, H. Parise, M. Fahy, and R. Mehran 5-Year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents J Am Coll Cardiol 54 2009 894 902
12. E.P. McFadden, E. Stabile, E. Regar, E. Cheneau, A.T. Ong, T. Kinnaird, W.O. Suddath, N.J. Weissman, R. Torguson, K.M. Kent, A.D. Pichard, L.F. Satler, R. Waksman, and P.W. Serruys Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 2004 1519 1521 (Pubitemid 39410418)
13. M. Pfisterer, H.P. Brunner-La Rocca, P.T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser BASKET-LATE Investigators Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2006 2584 2591 (Pubitemid 44881238)
14. S.J. Park, D.W. Park, Y.H. Kim, S.J. Kang, S.W. Lee, C.W. Lee, K.H. Han, S.W. Park, S.C. Yun, S.G. Lee, S.W. Rha, I.W. Seong, M.H. Jeong, S.H. Hur, N.H. Lee, J. Yoon, J.Y. Yang, B.K. Lee, Y.J. Choi, W.S. Chung, D.S. Lim, S.S. Cheong, K.S. Kim, J.K. Chae, D.Y. Nah, D.S. Jeon, K.B. Seung, J.S. Jang, H.S. Park, and K. Lee Duration of dual antiplatelet therapy after implantation of drug-eluting stents N Engl J Med 362 2010 1374 1382
15. J.R. Costa Jr, A. Sousa, A.C. Moreira, R.A. Costa, M. Cano, G. Maldonado, C. Campos, M. Carballo, R. Pavanello, and J.E. Sousa Incidence and predictors of very late (> or =4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)late registry JACC Cardiovasc Interv 3 2010 12 18
16. M.C. Morice, P.W. Serruys, P. Barragan, C. Bode, G.A. Van Es, H.P. Stoll, D. Snead, L. Mauri, D.E. Cutlip, and E. Sousa Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial J Am Coll Cardiol 50 2007 1299 1304 (Pubitemid 47454687)
17. J.J. Goy, P. Urban, U. Kaufmann, C. Seydoux, E. De Benedetti, and A. Berger Incidence of stent thrombosis and adverse cardiac events 5 years after sirolimus stent implantation in clinical practice Am Heart J 157 2009 883 888
18. P.W. Serruys, Y. Onuma, S. Garg, P. Vranckx, B. De Bruyne, M.C. Morice, A. Colombo, C. Macaya, G. Richardt, J. Fajadet, C. Hamm, M. Schuijer, T. Rademaker, K. Wittebols, H.P. Stoll ARTS II Investigators 5-Year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions J Am Coll Cardiol 55 2010 1093 1101
19. D. Planer, R. Beyar, Y. Almagor, S. Banai, V. Guetta, H. Miller, R. Kornowski, S. Brandes, R. Krakover, M. Solomon, and C. Lotan Long-term (>3 years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry) Am J Cardiol 101 2008 953 959
20. I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G.M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, N. Corvaja, C. Briguori, U. Gerckens, E. Grube, and A. Colombo Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130 (Pubitemid 40617065)
21. T. Kimura, T. Morimoto, K. Kozuma, Y. Honda, T. Kume, T. Aizawa, K. Mitsudo, S. Miyazaki, T. Yamaguchi, E. Hiyoshi, E. Nishimura, T. Isshiki RESTART Investigators Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART) Circulation 122 2010 52 61
22. M. Joner, A.V. Finn, A. Farb, E.K. Mont, F.D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H.K. Gold, and R. Virmani Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 220
23. C.W. Lee, S.J. Kang, D.W. Park, S.H. Lee, Y.H. Kim, J.J. Kim, S.W. Park, G.S. Mintz, and S.J. Park Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation J Am Coll Cardiol 55 2010 1936 1942
24. S. Cook, E. Ladich, G. Nakazawa, P. Eshtehardi, M. Neidhart, R. Vogel, M. Togni, P. Wenaweser, M. Billinger, C. Seiler, S. Gay, B. Meier, W.J. Pichler, P. Jni, R. Virmani, and S. Windecker Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis Circulation 120 2009 391 399
25. P.W. Serruys, J.A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H.M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 2009 897 910
26. A. Abizaid, M.A. Costa, M. Centemero, A.S. Abizaid, V.M. Legrand, R.V. Limet, G. Schuler, F.W. Mohr, W. Lindeboom, A.G. Sousa, J.E. Sousa, B. van Hout, P.G. Hugenholtz, F. Unger, P.W. Serruys Arterial Revascularization Therapy Study Group Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial Circulation 104 2001 533 538 (Pubitemid 32738121)
27. G. Weisz, M.B. Leon, D.R. Holmes Jr, D.J. Kereiakes, J.J. Popma, P.S. Teirstein, S.A. Cohen, H. Wang, D.E. Cutlip, and J.W. Moses Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De Novo Native Coronary Lesions) Trial J Am Coll Cardiol 53 2009 1488 1497